incyte corp (INCY:NASDAQ GS)
As of 8:10 PM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).
Key Executives - incyte corp (INCY)
| Name | Board Relationships | Title | Age |
| Paul A. Friedman M.D. | 61 Relationships | Chief Executive Officer, President, Director, Member of Non-Management Stock Option Committee and Member of Finance Committee | 69 |
| Roy A. Whitfield | 57 Relationships | Co-Founder, Director and Member of Audit Committee | 58 |
| David C. Hastings CPA | No Relationships | Chief Financial Officer and Executive Vice President | 50 |
| Laurent Chardonnet | No Relationships | Principal Accounting Officer, Vice President of Finance and Treasurer | 47 |
| James M. Daly | No Relationships | Chief Commercial Officer and Executive Vice President | 50 |
Board Members - incyte corp (INCY)
| Name | Board Relationships | Primary Company | Age |
| Richard U. De Schutter | 63 Relationships | Linden LLC | 71 |
| Paul A. Friedman M.D. | 61 Relationships | Incyte Corporation | 69 |
| Roy A. Whitfield | 57 Relationships | Incyte Corporation | 58 |
| Barry Michael Ariko | 25 Relationships | Globo Plc | 66 |
| Paul A. Brooke | 58 Relationships | WebMD Health Corp. | 66 |
Executive Committees* - incyte corp (INCY)
| Committee Name | Chairperson | Board Relationships | Members |
| Audit Committee | Barry Michael Ariko | 25 Relationships | 3 Executives |
| Compensation Committee | Paul A. Brooke | 58 Relationships | 4 Executives |
| Nominating Committee | Richard U. De Schutter | 63 Relationships | 3 Executives |
| Corporate Governance Committee | Richard U. De Schutter | 63 Relationships | 3 Executives |
| Finance Committee | Paul A. Brooke | 58 Relationships | 4 Executives |
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| INCY:US | $23.00 USD | +0.83 |  |
| Company | Last | Change |
| Ariad Pharmaceuticals Inc | $19.57 USD | +0.13 |
| Array BioPharma Inc | $5.85 USD | +0.19 |
| Evotec AG | €2.76 EUR | -0.024 |
| Exelixis Inc | $4.74 USD | -0.03 |
| Infinity Pharmaceuticals Inc | $24.30 USD | -0.06 |
| View Industry Companies | ||
Industry Analysis
INCY
Industry Average
| Valuation | INCY | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 9.3x |
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 7.6x |
|
Post a JobJobs
- Wilmington, DE | IncytePosted: May 21
- Wilmington, DE | IncytePosted: May 15
- Wilmington, DE | IncytePosted: May 06
- Wilmington, DE | IncytePosted: May 06
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact INCYTE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
